HUMULIN 70/30 PEN (INSULIN RECOMBINANT HUMAN; INSULIN SUSP ) — FDA Approval BLA019717 (LILLY)
HUMULIN 70/30 PEN (INSULIN RECOMBINANT HUMAN; INSULIN SUSP ) — FDA Approval BLA019717 (LILLY) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: HUMULIN 70/30 PEN; Active ingredients: INSULIN RECOMBINANT HUMAN; INSULIN SUSP ISOPHANE RECOMBINANT HUMAN; Application number: BLA019717.
| Brand name | HUMULIN 70/30 PEN |
|---|---|
| Active ingredients | INSULIN RECOMBINANT HUMAN; INSULIN SUSP ISOPHANE RECOMBINANT HUMAN |
| Application number | BLA019717 |
| Sponsor | LILLY |
| Dosage form | INJECTABLE |
| Route | INJECTION |
| Marketing status | Over-the-counter |
| Products in application | 2 |
| First approval date | 19890425 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →